Dr Reddys Laboratories announced the launch in the US market of Lenalidomide Capsules a therapeutic equivalent generic version of REVLIMID lenalidomide Capsules approved by U S Food and Drug Administration USFDA With this volume-limited launch Dr Reddys is eligible for first-to-market 180 days of generic drug exclusivity for Lenalidomide Capsules in 25 mg and 20 mg strengths
Gleam Fabmat announced that the 4th Annual General Meeting AGM of the company will be held on 29 September 2022
Himatsingka Seide announced that the Annual General Meeting AGM of the company will be held on 28 September 2022
Aries Agro announced that the 52nd Annual General Meeting AGM of the company will be held on 29 September 2022
Aris Intl announced that the 27th Annual General Meeting AGM of the company will be held on 30 September 2022
Sheetal Cool Products announced that the 9th Annual General Meeting AGM of the company will be held on 28 September 2022
Can Fin Homes announced the appointment of Arvind Narayan Yennemadi DIN07402047 and Anup Sankar Bhattacharya DIN02719232 as Non-executive and Independent Directors on the Board of Company with effect from 07 September 2022
Dhanada Corporation announced that the 36th Annual General Meeting AGM of the company will be held on 30 September 2022
Tata Consultancy Services has been recognized as a Leader in Everest Groups PEAK Matrix for Digital Twin Services TCS was placed highest for Market Impact Vision and Capability among the 16 IT service providers assessed in the report According to the report TCS strong set of digital twin specific solutions and its focus on embedding explainable AI in these solutions will aid enterprises accelerate and […]
Bank of Maharashtra has successfully raised Capital of Rs710 crore through private placement of BASEL III Compliant Additional Tier I Bonds The Bank received total bids of Rs1088 crore out of which Bank accepted bid of Rs710 crore full issue size at coupon rate of 874Percentage

IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.